Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Nidanilimab (anti-IL-1R3) is a fully humanized monoclonal anti-IL1RAP antibody with a Kd value of 1.10 pM. Nidanilimab (anti-IL-1R3) blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumour cells. Nidanilimab (anti-IL-1R3) can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC).
Nidanilimab (anti-IL-1R3) (Ab177848) - Flow Cytometry
Flow Cytometry analysis of Jurkat cells labelling IL-1R3 (red) with Nidanilimab (anti-IL-1R3) (Ab177848). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Nidanilimab (anti-IL-1R3) (Ab177848) - Flow Cytometry
Flow Cytometry analysis of HeLa cells labelling IL-1R3 (red) with Nidanilimab (anti-IL-1R3) (Ab177848). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Nidanilimab (anti-IL-1R3) (Ab177848) - Flow Cytometry
Flow Cytometry analysis of HepG2 cells labelling IL-1R3 (red) with Nidanilimab (anti-IL-1R3) (Ab177848). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Nidanilimab (anti-IL-1R3) (Ab177848) - SEC
The purity of Nidanilimab (anti-IL-1R3) (Ab177848) is more than 95% verified by HPLC.
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ23F1202011 | Certificate of Analysis | Dec 13, 2023 | Ab177848 |
| ZJ23F1202012 | Certificate of Analysis | Dec 13, 2023 | Ab177848 |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →
